Prognostic Value of Myocardial Contrast Delayed Enhancement With 64-Slice Multidetector Computed Tomography After Acute Myocardial Infarction  by Sato, Akira et al.
Journal of the American College of Cardiology Vol. 59, No. 8, 2012
© 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00Cardiac Imaging
Prognostic Value of Myocardial Contrast
Delayed Enhancement With 64-Slice Multidetector
Computed Tomography After Acute Myocardial Infarction
Akira Sato, MD,* Toshihiro Nozato, MD,† Hiroyuki Hikita, MD,† Daiki Akiyama, MD,†
Hidetaka Nishina, MD,* Tomoya Hoshi, MD,* Hideaki Aihara, MD,* Yuki Kakefuda, MD,*
Hiroaki Watabe, MD,* Michiaki Hiroe, MD,‡ Kazutaka Aonuma, MD*
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.10.890Tsukuba, Yokosuka, and Tokyo, JapanJACC JOURNAL CME
This article has been selected as the month’s JACC Journal CME
activity.
Accreditation and Designation Statement
The American College of Cardiology Foundation (ACCF) is
accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
physicians.
The ACCF designates this Journal-based CME activity for a
maximum of 1 AMA PRA Category 1 Credit(s). Physicians should
only claim credit commensurate with the extent of their participa-
tion in the activity.
Method of Participation and Receipt of CME Certificate
To obtain credit for JACC CME, you must:
1. Be an ACC member or JACC subscriber.
2. Carefully read the CME-designated article available online and
in this issue of the journal.
3. Answer the post-test questions. At least 2 out of the 3 questionsYokosuka Kyosai Hospital, Yokosuka, Japan; and the ‡Department of Car-
diology, International Medical Center of Japan, Tokyo, Japan. All authors have4. Complete a brief evaluation.
5. Claim your CME credit and receive your certificate electroni-
cally by following the instructions given at the conclusion of
the activity.
CME Objective for This Article: At the conclusion of this
activity, the learner should be able to evaluate the clinical value of
myocardial contrast delayed enhancement with multidetector com-
puted tomography for predicting clinical outcome after acute
myocardial infarction.
CME Editor Disclosure: JACC CME Editor Ajit Raisinghani,
MD, FACC, reports that he has no financial relationships or
interests to disclose.
Author Disclosures: All authors have reported that they have no
relationships relevant to the contents of this paper to disclose.
Medium of Participation: Print (article only); online (article and
quiz)
CME Term of Approval:
Issue date: February 21, 2012provided must be answered correctly to obtain CME credit. Expiration date: February 20, 2013From the *Cardiovascular Division, Graduate School of Comprehensive Human
Sciences, University of Tsukuba, Tsukuba, Japan; †Cardiovascular Center,reported that they have no relationships relevant to the contents of this paper to
disclose.Manuscript received July 5, 2011; revised manuscript received October 11, 2011,
accepted October 17, 2011.
731JACC Vol. 59, No. 8, 2012 Sato et al.
February 21, 2012:730–8 Prognostic Value of Delayed Enhancement MDCTPrognostic Value of Myocardial Contrast Delayed Enhancement With
64-Slice Multidetector Computed Tomography After Acute Myocardial Infarction
Objectives This study evaluated the clinical value of myocardial contrast delayed enhancement (DE) with multidetector
computed tomography (MDCT) for predicting clinical outcome after acute myocardial infarction (AMI).
Background Although some studies have described the use of MDCT for assessment of myocardial viability after AMI, clinical
experience remains limited.
Methods In 102 patients with first AMI, 64-slice MDCT without iodine reinjection was performed immediately following
successful percutaneous coronary intervention (PCI). We measured the size of myocardial contrast DE on MDCT
and compared it with clinical outcome. Primary composite cardiac events were cardiac death or hospitalization
for worsening heart failure.
Results Among the 102 patients (24  10 months follow-up), 19 patients experienced primary composite cardiac
events (cardiac death, n  7; heart failure, n  12). Kaplan-Meier analysis showed higher risk of cardiac events
for patients in the third tertile of myocardial contrast DE size (36 g) than for those in the other 2 tertiles
(p  0.0001). Multivariable Cox proportional hazards regression analysis indicated that myocardial contrast DE
size (adjusted hazard ratio [HR] for tertile 3 vs. 1: 16.1, 95% confidence interval [CI]: 1.45 to 72.4, p  0.022;
HR for tertile 3 vs. 2: 5.06, 95% CI: 1.25 to 22.7, p  0.039) was a significant independent predictor for cardiac
events after adjustment for Thrombolysis In Myocardial Infarction risk score, left ventricular ejection fraction,
total defect score on single-photon emission CT with technetium tetrofosmin, and transmural extent of myocar-
dial contrast DE on MDCT.
Conclusions Myocardial contrast DE size on MDCT immediately after primary PCI may provide promising information for
predicting clinical outcome in patients with AMI. (J Am Coll Cardiol 2012;59:730–8) © 2012 by the American
College of Cardiology FoundationPrimary percutaneous coronary intervention (PCI) has im-
proved the prognosis of patients with acute myocardial
infarction (AMI) (1); however, left ventricular (LV) remod-
eling occurs in an appreciable proportion of patients with
AMI, despite patency of and epicardial blood flow in the
infarct-related artery after primary PCI. LV remodeling
following AMI is a major predictor of morbidity and
mortality for overt congestive heart failure and life-
threatening arrhythmias (2). LV remodeling is predicted by
the extent of transmurality and infarct size after AMI (3).
Late gadolinium enhanced cardiac magnetic resonance im-
aging (MRI) is the current clinical standard for the assess-
ment of LV infarct size (4) and the prediction of functional
recovery and prognosis after AMI (5).
The recent advent of multidetector computed tomogra-
phy (MDCT) has enabled the detection of AMI (6),
whereas myocardial delayed enhancement (DE) on MDCT
demonstrates accurate measurement of infarct size in AMI,
analogous to hyperenhancement contrast-enhanced cardiac
MRI in animals (7) and humans (8). A preliminary study
recently showed that transmural contrast enhancement on
MDCT without iodine reinjection immediately after coro-
nary angiography for AMI correlated with nonviable myo-
cardium (9). We also demonstrated that myocardial contrast
DE patterns might be reliably useful in predicting functional
recovery of the post-ischemic myocardium and LV remodeling
in patients with AMI (10). Although some studies have
described the use of MDCT for assessment of myocardialviability after AMI, clinical experience remains limited (11).
Furthermore, whether the extent of myocardial contrast DE
adds prognostic information above that of angiographic and
LV functional parameters or traditional clinical risk stratifica-
tion, such as the Thrombolysis In Myocardial Infarction
(TIMI) risk score (12), is unclear. This study was designed to
evaluate the clinical value of myocardial contrast DE with
MDCT for predicting clinical outcome after AMI.
Methods
Study population. We initially assessed a prospective,
consecutive series of 110 patients with first AMI for
inclusion into the study from September 2006 to December
2007. AMI was defined as: 1) chest pain 30 min in
duration with presentation within 12 h after onset of
symptoms; 2) ST-segment elevation 0.1 mV within 2
contiguous electrocardiograph leads; and 3) elevated crea-
tine kinase-myocardial band (CK-MB) isoenzymes within
12 h of chest pain. All patients underwent detailed assess-
ment of medical history and a physical examination at the
index hospitalization. TIMI risk score was calculated for all
patients (12). Exclusion criteria were a history of previous
MI or heart failure and renal insufficiency (creatinine 1.5
mg/dl). Cardiogenic shock caused death in 2 patients, 1
patient died from noncardiac death due to cancer, 3 patients
refused to give their informed consent, and 2 patients were
lost to follow-up. The remaining 102 patients represent the
population of this study. Written informed consent was
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the study protocol was approved
by our institutional review board.
Coronary angiography and PCI
procedure. Experienced interven-
tional cardiologists performed coro-
nary angiography (CAG) through
the femoral approach with 6-F cath-
eters. The culprit coronary artery
was defined on the basis of electro-
cardiography (ECG) and CAG re-
sults. All patients underwent PCI
with both aspirin and a loading dose
of 300 mg clopidogrel. Glycoprotein
IIb/IIIa receptor antagonist was not
available for administration in Japan
at the time of the study. The con-
trast agent used was iopamidol
370 mg I/ml (Schering AG, Berlin,
Germany). Post-procedural optimal
coronary flow was defined as TIMI
flow grade3, and incomplete rep-
erfusion or lack of procedural success
was defined as TIMI flow grade 0 to
2 (13). Myocardial blush grade was
defined according to a previous
method (14). Good collateral flow
was defined as grade 2 or 3 (15).
Time to reperfusion was defined as
the period from time of onset of
symptoms to time of reperfusion.
All patients underwent 64-slice
MDCT with no additional contrast
medium administered immediately
following the final angiogram of the
rimary PCI procedure. Total contrast volume and time from last
oronary injection to initiation of the CT scan were measured. All
atients underwent follow-up CAG 6 months after the initial
rocedure.
4-slice MDCT scanning procedure. Scanning was per-
ormed with a 64  0.5 mm slice collimation CT scanner
Aquilion 64, Toshiba Medical Systems Corporation,
tawara, Japan) with a gantry rotation speed of 400 ms/
otation. Scanning was performed using a tube energy of 120
V and effective tube current of 250 mA at a table feed of 6.4
m/gantry rotation with beam pitch of 0.2 and a radiation
ose of 7.0  1.0 mSv. Acquisition of CT data and an ECG
race were automatically started during a 7- to 9-s breath-hold.
econstruction and analysis of 64-slice MDCT images.
nalysis of the scans was performed on a ZIOSTATION
orkstation (ZIOSOFT Inc., Tokyo, Japan). The original
xial CT images and multiplanar reformations were used for
nalysis of the myocardium. The images used for interpre-
ation and for quantitative analysis were reconstructed at a
lice thickness of 1 mm and an increment of 1 mm in the
Abbreviations
and Acronyms
99mTc  technetium
AMI  acute myocardial
infarction
BNP  B-type natriuretic
peptide
CAG  coronary
angiography
CI  confidence interval
CK-MB  creatine kinase-
myocardial band
DE  delayed enhancement
ECG  electrocardiography
EDV  end-diastolic volume
ESV  end-systolic volume
HR  hazard ratio
LV  left ventricular
LVEF  left ventricular
ejection fraction
MDCT  multidetector
computed tomography
MRI  magnetic resonance
imaging
PCI  percutaneous
coronary intervention
SI  signal intensity
SPECT  single-photon
emission computed
tomography
TDS  total defect scores
TIMI  Thrombolysis In
Myocardial Infarctioniastolic phase (75%) of the R–R interval. When the imagesere blurred by motion artifacts due to high heart rate (90
eats/min), systolic reconstructions were performed. Images
ere analyzed using a 17-segment model (16). Extent of
yperenhancement was judged as transmural if75% of the
V wall thickness in each segment of the axial, short-axis,
nd long-axis multiplanar images was visually involved and
ubendocardial if 75%. Infarct area was defined as a
yperenhancement with signal intensity (SI) higher than 2
D above the mean SI of remote normal myocardium (17).
nfarct size was calculated on the basis of graphics displayed
y SI histogram thresholding using a step-based algorithm
o detect voxels within the defined SI range in the 3
imensions and to define clusters of voxels that meet the
yperenhancement definition. Using this method, the ded-
cated software determined the mean SI of the hyperen-
ancement in HU and calculated total myocardial contrast
E size in grams (Fig. 1). The MDCT images were
nalyzed by 2 independent observers to calculate interob-
erver and intraobserver agreements in a random subset of
0 patients.
adionuclide imaging. ECG-gated myocardial single-
hoton emission computed tomography (SPECT) with tech-
etium (99mTc) tetrofosmin was performed at 1 week after
dmission. Imaging was performed at rest in the supine
osition 1 h after intravenous injection of 740 MBq 99mTc-
etrofosmin as the radiotracer using a double-detector SPECT
ystem (PICKER PRISM 2000 XP, Shimadzu Corporation,
yoto, Japan) equipped with a low-energy, high-resolution col-
imator. The radiation dose from a resting 99mTc-tetrofosmin
tudy averages 6.7 mSv (18). Data from 72 projections were
btained with a 64  64 matrix over 360° and were acquired
or 40 s for each projection. Total acquisition time was approx-
mately 24 min. Images were gated at 16 frames per cardiac cycle
ith an R-wave trigger, and calculation of standard parameters
imilar to left ventricular ejection fraction (LVEF), LV end-
iastolic volume (EDV), and LV end-systolic volume (ESV) were
rovided with commercially available software (19). SPECT
mages of the LV were divided into 17 segments (16), and each
egment was visually scored according to 4 grades (0  normal
ptake, 1  mildly decreased uptake, 2  moderately decreased
uptake, 3 severely decreased uptake). Total defect scores (TDS)
were calculated by summation.
Biochemical analysis. Serum CK-MB levels were ana-
lyzed by enzymatic means, and plasma B-type natriuretic
peptide (BNP) concentrations were measured with a specific
immunoradiometric commercial assay using a commercial
kit (Shionogi Inc., Osaka, Japan). Blood samples for plasma
BNP were obtained from all patients on hospital day 28
after admission.
Clinical endpoints. For the present analysis, the primary
composite cardiac events were defined as cardiac death or
hospitalization for worsening heart failure. Cardiac death
was defined as death due to myocardial infarction, conges-
tive heart failure, or documented sudden cardiac death. The
diagnosis of congestive heart failure was made on the basis
of the criteria in the Framingham Heart Study (20). Hospitaliza-
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February 21, 2012:730–8 Prognostic Value of Delayed Enhancement MDCTtion for worsening heart failure was defined as evidence of
pulmonary congestion on a chest radiograph and treat-
ment with intravenous diuretic therapy during hospital-
ization. When 2 events occurred simultaneously, the
ost severe event was chosen (death  heart failure).
fter hospital discharge, all patients were followed up
very month at our hospital’s outpatient clinic up to a
ean follow-up period of 24  10 months (range 2 weeks
o 34 months). Cardiac events were documented by
linical visits and standardized follow-up phone calls to
he patients or their families, followed by review of
edical records. The diagnosis of cardiac events was
djudicated by independent cardiologists who were
linded to the findings of CAG and CT imaging.
tatistical analysis. All data are expressed as the mean 
D or as median (interquartile range) for non-normally
istributed data. Comparisons of categorical variables be-
ween groups were performed by the chi-square test or
isher exact test. Comparisons of continuous variables were
nalyzed by unpaired t test or Mann-Whitney U test
ccording to the data distribution. Paired comparisons
A 
B 
Figure 1 Contrast DE Size Assessment by MDCT
Multidetector computed tomography (MDCT) images show the infarct area (red reg
above the mean SI of remote normal myocardium on (A) axial and (B) short-axis m
rithm to detect voxels within the defined SI range in the 3 dimensions and to defin
myocardial contrast delayed enhancement (DE) size in this patient was 63.4 g (blmong three groups were analyzed by 1-way analysis of mariance with the ad hoc multiple comparison method
Tukey-Kramer). Event-free survival curves for cardiac
vents were constructed by the Kaplan-Meier method,
nd statistical differences between curves were assessed by
og-rank test. Multivariable Cox proportional hazards
odels were developed to calculate hazard ratio (HR), 95%
onfidence interval (CI), and Wald chi-square test value.
inear regression analyses were performed with Pearson’s
orrelation coefficients. Interobserver and intraobserver vari-
nce was calculated as mean difference  SD. All probability
alues were considered significant when 0.05.
esults
atient characteristics. Baseline clinical characteristics of
he patients are summarized in Table 1. The median time
elay between last injection of contrast medium and
DCT scanning was 14  2.5 min (range 8 to 18 min).
ean heart rate during scanning was 78  17 beats/min
range 41 to 102 beats/min). Iodine volume injected during
CI was 196  23 ml (range 158 to 244 ml). The
RV 
Ao 
C 
efined as a hyperenhancement with a signal intensity (SI) higher than 2 SD
anar reconstructions. (C) Infarct size was calculated using a step-based algo-
ters of voxels that meet the hyperenhancement definition (green region). The
row). Ao  ascending aorta; RV  right ventricle.ion) d
ultipl
e clus
ack aryocardial contrast DE region of infarcted myocardium
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remote myocardium (76  12 HU) and LV cavity (99  19
HU; p  0.0001). Interobserver and intraobserver measure-
ents of myocardial contrast DE size on MDCT were
losely correlated (r  0.98, p  0.0001; and r  0.99, p 
.0001, respectively), and mean differences in myocardial
ontrast DE size were small (0.09  0.99 g and –1.60 
.71 g, respectively). All patients underwent stent implan-
ation in the infarct-related artery (Online Fig. 1). There
Biochemical Markers, CT, and Technetium-99m SPECT Findings AcTable 2 Biochemical Markers, CT, and Technetium-99m SPECT
All Patients
(N  102)
Peak CK-MB (IU/ml) 233 (97–437)
BNP on day 28 (pg/ml) 101 (32–245)
TIMI risk score 3.54 2.06
ST-segment resolution (%) 65 28
Angiographic characteristics (%)
Post-TIMI flow grade 3 92 (90)
Post-myocardial blush grade 3 46 (45)
Good collateral flow 14 (13)
CT measurements
Myocardial contrast DE size (g) 21.0 (7.31–40.9)
Transmural extent (n) 2 (0–6)
SPECT measurements
LVEF (%) 49.4 11.9
LVEDV (ml) 97.6 35.4
LVESV (ml) 52.3 28.3
Total defect score 15.6 11.1
Values are median (interquartile range [25% to 75%]), mean  SD, or n (%).
Clinical Characteristics of the Study PopulationTable 1 Clinical Characteristics of the Stud
Characteristic
All Patie
(N  10
Age (yrs) 63 1
Male 86 (84
Hypertension 42 (41
Dyslipidemia 68 (67
Diabetes 34 (33
Smoking 62 (61
Time to reperfusion (h) 4.5 3
Infarct location (anterior/inferior/lateral) 56/32/
Infarct-related artery (%)
LAD 56 (57
RCA 32 (31
LCX 14 (12
Medications after admission
Beta-blocker 58 (57
ACE inhibitor/ARB 91 (89
Calcium-channel blocker 32 (31
Statin 90 (88
Diuretic 34 (33
Values are mean  SD, n (%), or n.
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor
coronary artery.BNP  B-type natriuretic peptide; CK-MB  creatine kinase-myocardial band; CT  computed tomog
entricular ejection fraction; LVESV  left ventricular end-systolic volume; SPECT  single-photon emissiere 4 patients with binary restenosis (50% stenosis) of
he culprit coronary arteries at 6-month follow-up CAG.
iomarker, angiographic, MDCT, and SPECT findings
ccording to the cardiac events. There were no differences
n the incidence of post-TIMI flow grade 3, post-
yocardial blush grade 3, and recovery of ST-segment
esolution between the two groups (Table 2). Peak serum
K-MB, plasma BNP levels, mean infarct size, extent of
V segments with transmurality, LVEDV, LVESV, and
ing to the Cardiac Eventsings According to the Cardiac Events
Events ()
(n  19)
Events (–)
(n  83) p Value
648 (437–765) 153 (87–311) 0.001
277 (141–520) 73 (25–184) 0.001
4.68 1.73 3.28 2.05 0.007
46 9 68 29 0.155
15 (79) 77 (93) 0.082
7 (37) 39 (46) 0.187
2 (11) 12 (14) 0.239
60.0 (35.7–63.0) 13.7 (4.75–30.9) 0.001
7 (2–10) 1 (0–4) 0.001
43.8 8.5 50.7 12.3 0.024
113.0 33.5 93.9 34.9 0.025
66.1 26.2 49.2 27.9 0.018
25.1 9.7 13.3 10.1 0.001
rding to the Cardiac Eventsulation According to the Cardiac Events
Events ()
(n  19)
Events ()
(n  83) p Value
62 12 63 10 0.615
17 (89) 69 (83) 0.493
9 (47) 33 (40) 0.543
14 (73) 54 (65) 0.472
6 (32) 28 (34) 0.857
13 (68) 49 (59) 0.449
5.4 3.1 4.3 2.9 0.144
15/2/2 41/30/12 0.053
0.053
15 (80) 41 (49)
2 (10) 30 (36)
2 (10) 12 (14)
14 (74) 44 (53) 0.101
18 (95) 73 (88) 0.201
3 (16) 29 (34) 0.169
18 (95) 72 (87) 0.456
12 (63) 22 (27) 0.006
r; LAD  left anterior descending; LCX  left circumflex; RCA  rightcordFindAccoy Pop
nts
2)
0
)
)
)
)
)
.0
14
)
)
)
)
)
)
)
)raphy; DE  delayed enhancement; LVEDV  left ventricular end-diastolic volume; LVEF  left
on tomography; TIMI  Thrombolysis In Myocardial Infarction.
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February 21, 2012:730–8 Prognostic Value of Delayed Enhancement MDCTTDS were significantly higher in patients with cardiac
events than in patients without cardiac events, whereas
mean LVEF was significantly lower in patients with cardiac
events than in patients without cardiac events. There was a
significant positive correlation between myocardial contrast
DE size and peak CK-MB level (r 0.71, p 0.0001) and
DS (r  0.75, p  0.0001) (Fig. 2).
rognostic value of myocardial contrast DE size on
DCT. Among the 102 patients, 19 patients (18.6%) had
ardiac events during follow-up. Cardiac death occurred in
patients (6.9%), and 12 patients (11.8%) were hospitalized
uring follow-up because of worsening heart failure.
mong the 7 cardiac deaths, 2 patients died from docu-
ented sudden cardiac death due to ventricular fibrillation,
nd the remaining 5 patients died from refractory heart
ailure. We performed a tertile analysis of DE size on
DCT and related it to cardiac event–free survival rate. On
he basis of cutoff points of tertiles of DE size, the study
opulation was divided into 3 groups: tertile 1 (n  34),
11 g; tertile 2 (n  34), 11 to 36 g; and tertile 3
(n  34), 36 g. Kaplan-Meier analysis showed a higher
isk of cardiac events for patients within tertile 3 than for
hose within the other 2 tertiles (p  0.0001) (Fig. 3).
Univariate analysis (Table 3) indicated that TIMI risk
core, LVEF, TDS, tertile of myocardial contrast DE size,
nd the number of LV segments showing transmural extent
ere significantly associated with cardiac events. Cox pro-
ortional hazards regression analysis indicated that myocar-
ial contrast DE size (adjusted HR for tertile 3 vs. 1: 16.1,
5% CI: 1.45 to 72.4, p 0.022; HR for tertile 3 vs. 2: 5.06,
5% CI: 1.25 to 22.7, p  0.039) was a significant
ndependent predictor for cardiac events after adjustment for
IMI risk score, LVEF, TDS, and the number of LV
egments showing transmural extent (Table 4). A list of all
atients with their cardiac events and associated TIMI risk
Figure 2 Relation Between Contrast DE Size and Peak CK-MB
(A) Relation between delayed enhancement size and peak CK-MB levels (y  7.49
ment size and total defect score (y  0.36x  6.04, r  0.75, SEE  7.33, p 
TDS  total defect scores; other abbreviations as in Figure 1.core, LVEF, TDS, tertile of myocardial contrast DE size, andransmural extent of contrast DE are shown in Online Table 1.
ll patients with cardiac events had transmural infarction.
iscussion
he major important findings of the present study are as
ollows. First, myocardial contrast DE size was the most
owerful independent predictor for cardiac events after
MI, and second, the AMI patients with larger myocardial
ontrast DE size were at much higher risk of cardiac events
uring follow-up periods. Thus, in the setting of traditional
rognostic markers, determination of myocardial contrast
E size on MDCT images immediately after primary PCI
ay provide promising information for predicting clinical
utcome in patients with AMI. Although some reports have
ddressed viability imaging by MDCT, this is the first
eport, to our knowledge, to assess its prognostic value.
s, TDS
07, r  0.71, SEE  176, p  0.0001). (B) Relation between delayed enhance-
1). CK-MB  creatine kinase-myocardial band; SEE  standard error of estimate;
Figure 3 Kaplan-Meier Curves for Incidence of
Cardiac Events Defined by Contrast DE Size
Kaplan-Meier curves for the incidence of cardiac events defined by tertiles of
myocardial contrast delayed enhancement (DE) size. The three tertiles are
based on cutoff points of delayed enhancement size. Tertile 1 (n  34),
11 g; Tertile 2 (n  34), 11 to 36 g; Tertile 3 (n  34), 36 g.
Tertile 1 vs. 3: p  0.0001, Tertile 2 vs. 3: p  0.0009 log-rank test.Level
x  1
0.000
m
r
9) g; Te
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Prognostic Value of Delayed Enhancement MDCT February 21, 2012:730–8Myocardial infarct size onMDCT. Previous studies dem-
onstrated that contrast-enhanced MDCT can identify in-
farcted myocardium using an intravenous contrast injection
in occlusion/reperfusion animal models (7) and that 64-slice
CT without iodine reinjection immediately after coronary
angiography for AMI was a promising method of assessing
very early viability when dobutamine echocardiography and
delayed contrast-enhanced MRI were considered the refer-
ence methods (9). In addition, our previous study showing
that transmural contrast DE on MDCT revealed larger
infarct size and LV remodeling in the chronic phase,
followed by a greater incidence of hospitalization for wors-
ening heart failure, and indicated the clinical usefulness of
myocardial contrast DE patterns (10). The highly concen-
trated iodinated contrast agent injected during PCI and the
slow wash-in and wash-out from the damaged myocytes
provide myocardial infarction enhancement without addi-
tional contrast. In the present study, myocardial DE on
MDCT could be acquired with short time delay between
the last injection of contrast medium and MDCT scanning
because the MDCT room is next to the catheterization
laboratory in our institution. This time frame is unlikely to
be achieved in some hospitals. However, myocardial con-
trast DE could be identified as late as 40 min after contrast
injection (7). Therefore, if MDCT equipment is close to the
catheterization laboratory, this reliable procedure can be
clinically implemented in medical center hospitals.
Evaluation of infarct size and morphology with DE-MRI
has been well validated and is currently considered the
clinical gold standard for viability assessment (21,22). Be-
Univariate Analyses for Prediction of Cardiac EvTable 3 Univariate Analyses for Prediction o
Factor Hazard Ratio
TIMI risk score 1.31
Post-TIMI flow grade 0.26
SPECT measurements
LVEF (%) 0.95
LVEDV (ml) 1.01
LVESV (ml) 1.02
Total defect score 1.08
Extent of myocardial contrast DE size*
Tertile 3 vs. 1 18.70
Tertile 3 vs. 2 6.17
Transmural extent (n) 1.22
*Median (interquartile range [25% to 75%]): Tertile 1, 0.00 (0.00–7.4
Abbreviations as in Table 2.
Multivariable Cox Proportional Hazards Model foTable 4 Multivariable Cox Proportional Haza
Factor Hazard Ratio
Extent of myocardial contrast DE size*
Tertile 3 vs. 1 16.10
Tertile 3 vs. 2 5.06
Data were adjusted for the following variables related with cardiac eve
in Table 3. *Median (interquartile range [25% to 75%]): Tertile 1, 0
to 62.4) g.
Abbreviations as in Table 2.cause of its high contrast-to-noise ratio and lack of ionizing
radiation, DE-MRI is a highly attractive modality for
myocardial viability imaging. The spatial resolution of MRI
is quite high (1.5 to 2 mm). Although a certain partial
volume effect may contribute to an overestimation of infarct
size by DE-MRI, gadolinium accumulation in the intersti-
tium in viable myocardium and concomitant edema may be
seen as predominant factors (23). The excellent agreement
between the area of delayed contrast enhancement on
late-phase CT and DE-MRI is reported in various studies,
indicating the robustness of CT for viability imaging in
AMI (7,8). In addition, with its high isotropic resolution,
MDCT has the potential to greatly decrease partial volume
effects and accurately characterizes tissue compositions and
dynamic remodeling processes, as has been demonstrated
recently for the peri-infarct zone (24). In the present study,
the relation between DE size and total defect score evaluated
by 99mTc-tetrofosmin demonstrated quite scattered individual
easurements. Some patients without DE had slightly
educed uptake of 99mTc-tetrofosmin in the infarct territo-
ries. It might be postulated that myocardial damage such as
edema in cases of small infarction size is too little to enhance
the myocardium. In addition, localized attenuation by
overlying soft tissue or partial volume effect may create
artifacts that mimic true perfusion abnormalities.
Myocardial contrast DE size as a marker of long-term
clinical outcome. Most importantly in the present study, the
patients with larger myocardial contrast DE size had a greater
incidence of cardiac events and worse long-term prognosis
than those with smaller DE size. Because we could measure
diac Events
% Confidence Interval Wald Chi-Square p Value
1.06–1.60 6.43 0.011
0.11–1.15 4.43 0.097
0.91–0.99 4.93 0.026
0.99–1.03 4.25 0.106
0.99–1.04 4.62 0.076
1.04–1.12 15.60 0.001
2.46–61.1 8.28 0.001
1.78–21.2 8.04 0.001
1.10–1.35 14.10 0.001
rtile 2, 21.0 (13.9–30.1) g; Tertile 3, 50.1 (40.5–62.4) g.
diction of Cardiac Eventsodel for Prediction of Cardiac Events
% Confidence Interval Wald Chi-Square p Value
1.45–72.4 4.49 0.022
1.25–22.7 4.26 0.039
0.05): TIMI risk score, LVEF, total defect score, and transmural extent
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February 21, 2012:730–8 Prognostic Value of Delayed Enhancement MDCTinfarct size on MDCT just after primary PCI, our results
suggested that myocardial contrast DE size could be an early
predictive marker for future cardiac events. The number of LV
segments with transmural DE (infarct size) has been shown to
be a major factor for the prediction of remodeling (3), and
moreover, infarct size is a prognostic predictor after AMI (25).
Infarct size, anterior infarct location, perfusion status, and
congestive heart failure on admission are reported to be major
predictors of LV remodeling (2). In the present study, patients
ith larger myocardial contrast DE size had higher levels of
eak CK-MB and plasma BNP, which are useful biomarkers
f LV remodeling and poor clinical outcome. The 18.6%
ardiac event rate of this study may appear to be slightly high
ompared with that of a previous study (26). The reason for
his event rate may be because the patients included in the
resent study had higher TIMI risk scores. It is possible to
how the correlation between myocardial DE size on MDCT
nd clinical outcome, and furthermore, it is potentially feasible
o implement such a procedure clinically. Only 57% of our
tudy population was treated with a beta-blocker after admis-
ion, which is very low in comparison with the U.S. population
ith AMI. It has been reported that even for patients with
yocardial ischemia, calcium antagonists are preferred over
eta-blockers for the treatment of angina, maybe from fear of
oronary spasm, the rate of which is reported to be higher in
apanese than in Westerners (27).
linical implications. Contrast-enhanced MRI is well es-
ablished for the assessment of myocardial viability without
onizing radiation and nephrotoxic contrast material. However,
he facts that MDCT can be performed with short examina-
ion times and that it is generally available and easily performed
re considered important advantages in comparison with
ontrast-enhanced MRI. Furthermore, myocardial contrast
E size may be a very early predictive marker for future clinical
ardiac events and may add incremental prognostic value over
hat of classical parameters such as LVEF and TIMI risk score.
urther large studies to confirm these findings in clinical
xaminations are needed.
tudy limitations. First, radiation dose levels were high. If
nly end-diastolic images were used for data analysis, the
se of an ECG-pulsing technique or prospective ECG
riggering could have provided a significant dose reduction
28). Post-infarction DE has been successfully performed at
ow kV settings (80 kV), drastically reducing radiation dose
nd improving contrast visualization at the same time (9).
ual-energy scanning would definitely allow better assess-
ent and eventually reduce the radiation dose (29). Second,
he sample size was relatively small. The prognosis of our
atients receiving primary PCI was good, and multivariate
esting was limited due to the small number of endpoints.
herefore, the ability to predict cardiac events could be
imited. Third, the definition of hyperenhancement was not
tandardized, so there was a limitation due to the use of a
lobal classification, in particular for patients with both
ransmural and subendocardial hyperenhancement. We ap-
lied previously published signal density threshold algo-rithms to define the infarct region. However, specific
optimal cutoff values for normal and infarct cores are
unknown and are likely dependent on study quality. Finally,
areas of microvascular obstruction could not be detected
exactly with MDCT using direct acquisition of the late
phase in the present study. AMI is associated with myocar-
dial edema (23), and therefore, this might also influence the
extent of myocardial contrast DE in the present study. It is
possible that the prognostic value of the extent of DE on
MDCT is a reflection not only of the extent of necrosis but
also, at least in part, of the area at risk.
Conclusions
This study demonstrates that myocardial contrast DE size
on MDCT images obtained immediately after primary PCI
may provide promising information for predicting clinical
outcome in patients with AMI.
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APPENDIX
For clinical characteristics of patients with cardiac events and an example
of a transmural anteroseptal acute myocardial infarction, please see thetrast for the detection and assessment of myocardial infarction.
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